Research Reflections: Braunstein Breaks Down Top ASCO 2020 Abstracts in Myeloma
Season 3, Episode 29, Aug 13, 2020, 07:31 PM
In our exclusive interview, Marc J. Braunstein, MD, PhD, provided perspective on data in the up-front and relapsed/refractory settings regarding the use of triplet and quadruplet regimens, novel agents, and cellular therapies.